Developer docs
API playgroundTry for free, no card

Search company profiles

CV Sciences

Full company profile

uuid00069e2

Namestring
CV Sciences
Legal namestring
CV Sciences, Inc.
Websiteurl
cvsciences.com
Company typeenum
Public
Founded yearint
2007
Descriptiontext

CV Sciences, Inc. (OTCQB: CVSI) is a publicly traded consumer wellness company founded in 2007 and headquartered in San Diego, California, with additional operations in Grand Junction, Colorado, and Warsaw, Poland. The company specializes in hemp-derived and plant-based nutraceuticals, anchored by its flagship +PlusCBD brand — the top-selling hemp-extract brand in the U.S. natural products market according to SPINS — and a clinical evidence base including human clinical research, three published clinical case studies on PubMed.gov, and self-affirmed GRAS status, a regulatory milestone not previously achieved by a hemp extract supplement brand.

The product portfolio is organized across multiple sub-brands: +PlusCBD (oils, gummies, softgels, tinctures, pet products); +PlusHLTH (a cannabinoid-free supplement line targeting personalized wellness with clinically studied ingredients such as PEA, OEA, NMN, and berberine across cardiovascular, cognitive, cellular energy, magnesium balance, mobility, and appetite control); EMPOWR (a plant-based protein and creatine formula); Ignite (a men's performance formula); plus subsidiaries Elevated Softgels (contract softgel and tincture manufacturing), Cultured Foods (plant-based foods for EU distribution), and Lunar Fox Food Co. The portfolio spans 35+ recent product launches with 39–43% of net revenue attributed to products introduced since January 2023.

Revenue is generated through direct-to-consumer e-commerce (pluscbdoil.com, cvsciences.com with subscription options and free shipping above $45), B2B wholesale distribution, U.S. retail store partnerships, and EU/international distribution via Cultured Foods, supplemented by contract manufacturing services through Elevated Softgels. FY 2025 revenue was $13.8 million (down 12.2% YoY) with gross margin of 49.0% and operating expenses reduced 17.2% to $7.7 million. The company acquired Extract Labs (announced November 2024), Elevated Softgels, and Cultured Foods to expand manufacturing capacity and international reach, completed a March 2026 debt restructuring converting notes into common shares at $0.06 per share, and is positioning for a potential Medicare/Medicaid CBD pilot program targeted at senior reimbursement.

Short descriptiontext

CV Sciences is a publicly traded consumer wellness company specializing in hemp-derived and plant-based nutraceuticals, anchored by its flagship +PlusCBD brand and a growing portfolio of +PlusHLTH personalized supplements, serving health-conscious consumers, men 35+, seniors, and B2B partners across the U.S. and EU markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
hemp extract supplements, CBD wellness products, plant-based nutrition, nutraceutical supplements, encapsulated softgels
Industry5 codes
1CBD/Hemp Wellness & Supplements Retail
CodeCRANAHACPrimaryYes
2CBD/Hemp Specialty Stores (Tinctures, Oils, Edibles)
CodeCRANAHAAPrimaryNo
3Herbal & Botanical Supplements
CodeCRADAGADPrimaryNo
4CBD/Hemp Pet Products Retail
CodeCRANAHAFPrimaryNo
5Hemp & CBD Product Wholesale Distribution
CodeCRAOAIAGPrimaryNo
NAICS code2 codes
  • Medicinal and Botanical Manufacturing325411
  • Food (Health) Supplement Retailers456191
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Nutraceutical Supplements
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Hemp Extract and CBD Products
TypeOne Time License
Description

Sale of +PlusCBD branded hemp extract products including oils, gummies, softgels, and tinctures through retail and e-commerce channels. Revenue is generated from product sales at varying price points with subscription options available.

cvsciences.com
2Non-Cannabinoid Supplements (+PlusHLTH)
TypeOne Time License
Description

Sale of cannabinoid-free supplements under +PlusHLTH brand targeting personalized wellness, including products for cardiovascular health, cognitive function, cellular energy, mobility, and appetite control.

ir.cvsciences.com
3Plant-Based Foods (Cultured Foods)
TypeOne Time License
Description

Contract manufacturing and branded products for the nutraceutical and plant-based food industries through the company's Cultured Foods subsidiary, with distribution primarily across the EU and select international markets.

cvsciences.com
4Manufacturing Services (Elevated Softgels)
TypeProfessional Services
Description

The company owns Elevated Softgels, a leading manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry, providing manufacturing services to other companies.

cvsciences.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D
Pricing details1 tier
1Standard product pricing with free shipping threshold
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Free shipping on orders over $45. Subscribe and save options available.

cvsciences.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

CV Sciences develops, manufactures, and distributes science-backed hemp extract supplements under the +PlusCBD brand, cannabinoid-free wellness supplements under +PlusHLTH, plant-based protein and creatine formulas (EMPOWR), men's performance products (Ignite), and pet CBD products. The company also operates contract manufacturing through Elevated Softgels and plant-based foods through Cultured Foods, selling through direct-to-consumer e-commerce, U.S. retail stores, wholesale B2B channels, and international distribution.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Revenue of $13.8 million in FY 2025 with 49% gross margin and positive adjusted EBITDA of $0.1 million in Q4 2025
+2 more records
Product overview1 text field

CV Sciences operates as a consumer wellness company with a multi-brand product portfolio organized around science-backed natural ingredients and supplements. The core offering centers on +PlusCBD™ hemp extract products (top-selling brand in natural products market), complemented by the cannabinoid-free +PlusHLTH™ supplement line featuring personalized wellness solutions including Pulse, Cerebral, Restore, Trinity, Movement, and Regulate. The company also offers functional nutrition products like EMPOWR (plant-based protein and creatine) and Ignite (men's performance formula), alongside subsidiary brands including Elevated Softgels (softgel manufacturing), Cultured Foods™ (plant-based foods for EU markets), Lunar Fox Food Co. (plant-based foods), and +PlusCBD pet products. The portfolio spans B2B and B2C sales channels, combining hemp-derived supplements with broader wellness and nutrition offerings.

Product and service16 records
1+PlusCBD
CategoryHemp Extract Supplements
Description

Hemp extract supplement brand and CV Sciences' flagship product line spanning oils, gummies, softgels, and tinctures. Top-selling hemp-extract brand in the U.S. natural products market according to SPINS. Sold through e-commerce, U.S. retail, and wholesale channels for adult consumers seeking CBD-based wellness support.

2+PlusHLTH
CategoryCannabinoid-Free Supplements
Description

Cannabinoid-free supplement line delivering targeted formulations for personalized wellness, including cardiovascular health, cognitive function, cellular energy, magnesium balance, mobility, and appetite control. Built on Health Intelligence approach using clinically studied ingredients.

3EMPOWR
CategoryFunctional Nutrition
Description

Plant-based protein and creatine powder for total wellness containing 20g of protein from pea, hemp, and sunflower blend, 5g of creatine, and LactoSpore probiotics supporting muscle maintenance, cellular energy, and digestive balance.

4Ignite
CategoryMen's Wellness Supplements
Description

Men's performance formula for men aged 35+ combining Tongkat Ali, Panax ginseng, and Tribulus Terrestris botanicals with full spectrum CBD to support vitality, recovery, libido, and focus.

5Lunar Fox Food Co.
CategoryPlant-Based Foods
Description

Plant-based food brand offering vegan, gluten-free, and flexitarian products distributed through CV Sciences' sales channels.

6Elevated Softgels
CategoryContract Manufacturing
Description

Leading manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry, serving as in-house manufacturing capability for CV Sciences while also providing contract manufacturing services to other brands.

7Cultured Foods
CategoryPlant-Based Foods and Contract Manufacturing
Description

Subsidiary specializing in contract manufacturing and branded products for the nutraceutical and plant-based food industries, with distribution primarily across the EU and select international markets, offering vegan, gluten-free, and flexitarian products.

8Pulse
CategoryCannabinoid-Free Supplements
Description

Cardiovascular health and circulation supplement from the +PlusHLTH line supporting heart health, circulation, and cellular energy.

9Cerebral
CategoryCannabinoid-Free Supplements
Description

Long-term brain health and cognitive performance supplement from the +PlusHLTH line targeting focus, neurological resilience, and mental fatigue reduction.

10Restore
CategoryCannabinoid-Free Supplements
Description

Cellular energy and healthy aging supplement from the +PlusHLTH line supporting cellular energy, repair, and resilience for recovery and vitality.

11Trinity
CategoryCannabinoid-Free Supplements
Description

Magnesium supplement from the +PlusHLTH line using three bioavailable forms to support muscle function, nerve signaling, and cellular energy.

12Movement
CategoryCannabinoid-Free Supplements
Description

Mobility and physical comfort supplement from the +PlusHLTH line powered by PEA to reduce soreness, support joint function, and improve everyday wellbeing.

13Regulate
CategoryCannabinoid-Free Supplements
Description

Appetite control and satiety supplement from the +PlusHLTH line powered by OEA to support natural satiety signals and appetite awareness.

14+PlusCBD Extra Support Sleep and Calm Gummies
CategoryHemp Extract Supplements
Description

CBD gummies designed to support sleep and calm, combining the company's award-winning CBD with additional supportive ingredients.

15+PlusCBD Reserve Gummies
CategoryHemp Extract Supplements
Description

Premium tier CBD gummies representing the company's premium product offering in the gummy format.

16+PlusCBD Pet Products
CategoryHemp Extract Supplements
Description

CBD products specifically formulated for pets, expanding the +PlusCBD line to animal wellness applications.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-11-21
Description

CV Sciences entered into a definitive agreement to acquire Extract Labs as part of the company's strategy to expand its portfolio in hemp extracts and wellness products. This acquisition represents a strategic expansion of manufacturing capabilities and product offerings.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Joy Organics is a CBD wellness brand offering premium tinctures, gummies, softgels, and topicals sold primarily through DTC, directly overlapping with +PlusCBD's premium positioning in the natural products channel.

TypeDirect peer
Description

Charlotte's Web is the most direct U.S. competitor to +PlusCBD, offering a similarly broad portfolio of hemp-derived CBD oils, gummies, capsules, and topicals sold through natural products retail and DTC e-commerce.

TypeDirect peer
Description

cbdMD is a publicly traded CBD wellness company with overlapping product formats (oils, gummies, softgels, topicals) and a similar multi-channel DTC and retail distribution strategy across the U.S. natural products and mass channels.

TypeBroad incumbent
Description

Irwin Naturals is a broader nutritional supplement incumbent with a CBD sub-line (Irwin CBD) and extensive mass retail distribution, providing a relevant comparable for softgel manufacturing capability and broader supplement reach.

TypeDirect peer
Description

Lazarus Naturals is a hemp extract brand with a strong direct-to-consumer focus and comparable tincture, capsule, and topical product formats, making it a direct competitor in the value and premium CBD segments.

TypeDirect peer
Description

CBDistillery offers a comparable portfolio of CBD tinctures, capsules, gummies, and topicals under a vertically integrated model, competing head-to-head with +PlusCBD in the natural and online supplement channels.

TypeDirect peer
Description

Medterra sells a comparable range of CBD tinctures, gummies, capsules, and topicals through DTC and retail, with a similar focus on third-party testing and clinically oriented positioning.

TypeBroad incumbent
Description

Cronos Group is a larger publicly traded cannabis and wellness company with hemp-derived CBD products (including the Lord Jones brand) sold through similar premium and natural products retail channels, providing a broader category benchmark.

TypeBroad incumbent
Description

Herbalife is a global nutrition and supplement company with a broad botanical, protein, and wellness portfolio, providing a relevant comparable for the +PlusHLTH and EMPOWR supplement and plant-based protein lines that CV Sciences is expanding into.

TypeDirect peer
Description

Elixinol is a global hemp-derived CBD and botanical supplement brand with overlapping product formats (oils, capsules, topicals) and a similar evidence-led, clinically supported brand positioning to +PlusCBD.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CV Sciences

Nutraceutical Supplementscvsciences.com

CV Sciences is a publicly traded consumer wellness company specializing in hemp-derived and plant-based nutraceuticals, anchored by its flagship +PlusCBD brand and a growing portfolio of +PlusHLTH personalized supplements, serving health-conscious consumers, men 35+, seniors, and B2B partners across the U.S. and EU markets.

What CV Sciences does

CV Sciences, Inc. (OTCQB: CVSI) is a publicly traded consumer wellness company founded in 2007 and headquartered in San Diego, California, with additional operations in Grand Junction, Colorado, and Warsaw, Poland. The company specializes in hemp-derived and plant-based nutraceuticals, anchored by its flagship +PlusCBD brand — the top-selling hemp-extract brand in the U.S. natural products market according to SPINS — and a clinical evidence base including human clinical research, three published clinical case studies on PubMed.gov, and self-affirmed GRAS status, a regulatory milestone not previously achieved by a hemp extract supplement brand.

The product portfolio is organized across multiple sub-brands: +PlusCBD (oils, gummies, softgels, tinctures, pet products); +PlusHLTH (a cannabinoid-free supplement line targeting personalized wellness with clinically studied ingredients such as PEA, OEA, NMN, and berberine across cardiovascular, cognitive, cellular energy, magnesium balance, mobility, and appetite control); EMPOWR (a plant-based protein and creatine formula); Ignite (a men's performance formula); plus subsidiaries Elevated Softgels (contract softgel and tincture manufacturing), Cultured Foods (plant-based foods for EU distribution), and Lunar Fox Food Co. The portfolio spans 35+ recent product launches with 39–43% of net revenue attributed to products introduced since January 2023.

Revenue is generated through direct-to-consumer e-commerce (pluscbdoil.com, cvsciences.com with subscription options and free shipping above $45), B2B wholesale distribution, U.S. retail store partnerships, and EU/international distribution via Cultured Foods, supplemented by contract manufacturing services through Elevated Softgels. FY 2025 revenue was $13.8 million (down 12.2% YoY) with gross margin of 49.0% and operating expenses reduced 17.2% to $7.7 million. The company acquired Extract Labs (announced November 2024), Elevated Softgels, and Cultured Foods to expand manufacturing capacity and international reach, completed a March 2026 debt restructuring converting notes into common shares at $0.06 per share, and is positioning for a potential Medicare/Medicaid CBD pilot program targeted at senior reimbursement.

CV Sciences firmographics

Firmographics
Name
CV Sciences
Legal name
CV Sciences, Inc.
Website
https://cvsciences.com
Company type
Public
Founded year
2007
Operating status
Operating
Headcount range
11–50 employees
Short description
CV Sciences is a publicly traded consumer wellness company specializing in hemp-derived and plant-based nutraceuticals, anchored by its flagship +PlusCBD brand and a growing portfolio of +PlusHLTH personalized supplements, serving health-conscious consumers, men 35+, seniors, and B2B partners across the U.S. and EU markets.
Ownership category
akta.pro rank

CV Sciences industry classification

Industry
Product category
Nutraceutical Supplements
NAICS
Medicinal and Botanical Manufacturing (325411), Food (Health) Supplement Retailers (456191)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro primary industry
CBD/Hemp Wellness & Supplements Retail (CRANAHAC)
akta.pro secondary industries
CBD/Hemp Specialty Stores (Tinctures, Oils, Edibles) (CRANAHAA), Herbal & Botanical Supplements (CRADAGAD), CBD/Hemp Pet Products Retail (CRANAHAF), Hemp & CBD Product Wholesale Distribution (CRAOAIAG)

Keywords

  • Hemp extract supplements
  • CBD wellness products
  • Plant-based nutrition
  • Nutraceutical supplements
  • Encapsulated softgels

Where CV Sciences is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices4 records

Markets served

CV Sciences business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D

Revenue model

  1. Hemp Extract and CBD Products: Sale of +PlusCBD branded hemp extract products including oils, gummies, softgels, and tinctures through retail and e-commerce channels. Revenue is generated from product sales at varying price points with subscription options available.
  2. Non-Cannabinoid Supplements (+PlusHLTH): Sale of cannabinoid-free supplements under +PlusHLTH brand targeting personalized wellness, including products for cardiovascular health, cognitive function, cellular energy, mobility, and appetite control.
  3. Plant-Based Foods (Cultured Foods): Contract manufacturing and branded products for the nutraceutical and plant-based food industries through the company's Cultured Foods subsidiary, with distribution primarily across the EU and select international markets.
  4. Manufacturing Services (Elevated Softgels): The company owns Elevated Softgels, a leading manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry, providing manufacturing services to other companies.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard product pricing with free shipping threshold

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

CV Sciences product offering

Product offering

Core offering

CV Sciences develops, manufactures, and distributes science-backed hemp extract supplements under the +PlusCBD brand, cannabinoid-free wellness supplements under +PlusHLTH, plant-based protein and creatine formulas (EMPOWR), men's performance products (Ignite), and pet CBD products. The company also operates contract manufacturing through Elevated Softgels and plant-based foods through Cultured Foods, selling through direct-to-consumer e-commerce, U.S. retail stores, wholesale B2B channels, and international distribution.

Product overview

CV Sciences operates as a consumer wellness company with a multi-brand product portfolio organized around science-backed natural ingredients and supplements. The core offering centers on +PlusCBD™ hemp extract products (top-selling brand in natural products market), complemented by the cannabinoid-free +PlusHLTH™ supplement line featuring personalized wellness solutions including Pulse, Cerebral, Restore, Trinity, Movement, and Regulate. The company also offers functional nutrition products like EMPOWR (plant-based protein and creatine) and Ignite (men's performance formula), alongside subsidiary brands including Elevated Softgels (softgel manufacturing), Cultured Foods™ (plant-based foods for EU markets), Lunar Fox Food Co. (plant-based foods), and +PlusCBD pet products. The portfolio spans B2B and B2C sales channels, combining hemp-derived supplements with broader wellness and nutrition offerings.

Differentiator

Problem solved

Functional benefit

Products and services

  • +PlusCBD Hemp extract supplement brand and CV Sciences' flagship product line spanning oils, gummies, softgels, and tinctures. Top-selling hemp-extract brand in the U.S. natural products market according to SPINS. Sold through e-commerce, U.S. retail, and wholesale channels for adult consumers seeking CBD-based wellness support.
  • +PlusHLTH Cannabinoid-free supplement line delivering targeted formulations for personalized wellness, including cardiovascular health, cognitive function, cellular energy, magnesium balance, mobility, and appetite control. Built on Health Intelligence approach using clinically studied ingredients.
  • EMPOWR Plant-based protein and creatine powder for total wellness containing 20g of protein from pea, hemp, and sunflower blend, 5g of creatine, and LactoSpore probiotics supporting muscle maintenance, cellular energy, and digestive balance.
  • Ignite Men's performance formula for men aged 35+ combining Tongkat Ali, Panax ginseng, and Tribulus Terrestris botanicals with full spectrum CBD to support vitality, recovery, libido, and focus.
  • Lunar Fox Food Co. Plant-based food brand offering vegan, gluten-free, and flexitarian products distributed through CV Sciences' sales channels.
  • Elevated Softgels Leading manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry, serving as in-house manufacturing capability for CV Sciences while also providing contract manufacturing services to other brands.
  • Cultured Foods Subsidiary specializing in contract manufacturing and branded products for the nutraceutical and plant-based food industries, with distribution primarily across the EU and select international markets, offering vegan, gluten-free, and flexitarian products.
  • Pulse Cardiovascular health and circulation supplement from the +PlusHLTH line supporting heart health, circulation, and cellular energy.
  • Cerebral Long-term brain health and cognitive performance supplement from the +PlusHLTH line targeting focus, neurological resilience, and mental fatigue reduction.
  • Restore Cellular energy and healthy aging supplement from the +PlusHLTH line supporting cellular energy, repair, and resilience for recovery and vitality.
  • Trinity Magnesium supplement from the +PlusHLTH line using three bioavailable forms to support muscle function, nerve signaling, and cellular energy.
  • Movement Mobility and physical comfort supplement from the +PlusHLTH line powered by PEA to reduce soreness, support joint function, and improve everyday wellbeing.
  • Regulate Appetite control and satiety supplement from the +PlusHLTH line powered by OEA to support natural satiety signals and appetite awareness.
  • +PlusCBD Extra Support Sleep and Calm Gummies CBD gummies designed to support sleep and calm, combining the company's award-winning CBD with additional supportive ingredients.
  • +PlusCBD Reserve Gummies Premium tier CBD gummies representing the company's premium product offering in the gummy format.
  • +PlusCBD Pet Products CBD products specifically formulated for pets, expanding the +PlusCBD line to animal wellness applications.

Quantifiable outcome

  • Revenue of $13.8 million in FY 2025 with 49% gross margin and positive adjusted EBITDA of $0.1 million in Q4 2025
  • +2 more outcomes

Companies that use CV Sciences

Customer profile

Segments5 records

Ideal customer profiles4 records

CV Sciences technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

CV Sciences partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Extract LabscoreStrategic or Co-development Partner · 21 November 2024CV Sciences entered into a definitive agreement to acquire Extract Labs as part of the company's strategy to expand its portfolio in hemp extracts and wellness products. This acquisition represents a strategic expansion of manufacturing capabilities and product offerings.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

CV Sciences competitors and assessment

Company assessment

Direct peers

  • Joy Organics: Joy Organics is a CBD wellness brand offering premium tinctures, gummies, softgels, and topicals sold primarily through DTC, directly overlapping with +PlusCBD's premium positioning in the natural products channel.
  • Charlotte's Web Holdings: Charlotte's Web is the most direct U.S. competitor to +PlusCBD, offering a similarly broad portfolio of hemp-derived CBD oils, gummies, capsules, and topicals sold through natural products retail and DTC e-commerce.
  • cbdMD: cbdMD is a publicly traded CBD wellness company with overlapping product formats (oils, gummies, softgels, topicals) and a similar multi-channel DTC and retail distribution strategy across the U.S. natural products and mass channels.
  • Lazarus Naturals: Lazarus Naturals is a hemp extract brand with a strong direct-to-consumer focus and comparable tincture, capsule, and topical product formats, making it a direct competitor in the value and premium CBD segments.
  • CBDistillery: CBDistillery offers a comparable portfolio of CBD tinctures, capsules, gummies, and topicals under a vertically integrated model, competing head-to-head with +PlusCBD in the natural and online supplement channels.
  • Medterra: Medterra sells a comparable range of CBD tinctures, gummies, capsules, and topicals through DTC and retail, with a similar focus on third-party testing and clinically oriented positioning.
  • Elixinol: Elixinol is a global hemp-derived CBD and botanical supplement brand with overlapping product formats (oils, capsules, topicals) and a similar evidence-led, clinically supported brand positioning to +PlusCBD.

Broad incumbents

  • Irwin Naturals: Irwin Naturals is a broader nutritional supplement incumbent with a CBD sub-line (Irwin CBD) and extensive mass retail distribution, providing a relevant comparable for softgel manufacturing capability and broader supplement reach.
  • Cronos Group: Cronos Group is a larger publicly traded cannabis and wellness company with hemp-derived CBD products (including the Lord Jones brand) sold through similar premium and natural products retail channels, providing a broader category benchmark.
  • Herbalife: Herbalife is a global nutrition and supplement company with a broad botanical, protein, and wellness portfolio, providing a relevant comparable for the +PlusHLTH and EMPOWR supplement and plant-based protein lines that CV Sciences is expanding into.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

CV Sciences social profiles

Digital presence

CV Sciences compliance and trust

Trust signal

Compliance1 record

CV Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CV Sciences leadership team

Management profile

Number of profiles

Profiles4 records

CV Sciences subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

CV Sciences funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CV Sciences M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CV Sciences

What does CV Sciences do?

CV Sciences develops, manufactures, and distributes science-backed hemp extract supplements under the +PlusCBD brand, cannabinoid-free wellness supplements under +PlusHLTH, plant-based protein and creatine formulas (EMPOWR), men's performance products (Ignite), and pet CBD products. The company also operates contract manufacturing through Elevated Softgels and plant-based foods through Cultured Foods, selling through direct-to-consumer e-commerce, U.S. retail stores, wholesale B2B channels, and international distribution.

Is CV Sciences a public or private company?

CV Sciences is a public company. It is classified as public and is currently operating.

When was CV Sciences founded?

CV Sciences was founded in 2007. It employs 11 to 50 people.

Where is CV Sciences based?

CV Sciences is headquartered in San Diego, United States, in the North America region.

How does CV Sciences make money?

Four revenue lines are on record. Hemp Extract and CBD Products are the primary driver. The others are non-Cannabinoid Supplements (+PlusHLTH), plant-Based Foods (Cultured Foods) and manufacturing Services (Elevated Softgels).

Who are CV Sciences's main competitors?

Direct peers on record are Joy Organics, Charlotte's Web Holdings, cbdMD, Lazarus Naturals, CBDistillery, Medterra and Elixinol. Broad incumbents are Irwin Naturals, Cronos Group and Herbalife.

Does CV Sciences have an API?

No public API is recorded for CV Sciences.

What industry is CV Sciences in?

CV Sciences's product category is Nutraceutical Supplements. Its primary akta.pro industry code is CRANAHAC, CBD/Hemp Wellness & Supplements Retail, with a secondary code of CRANAHAA, CBD/Hemp Specialty Stores (Tinctures, Oils, Edibles). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AInvestCV Sciences Just "Welcomed" a 30-Day Stay. Stays Aren't Rescues.CV Sciences' CEO welcomed a one-month delay on a federal hemp rule, moving the deadline from November 12 to December 11, 2026. The rule limits hemp products to 0.4 mg of total THC per container, which would reclassify most current products as marijuana. The company lost $1.42 million in the first half of 2026 and has about $0.27 million in cash.Markets DailyCV Sciences Q2 Earnings Call HighlightsCV Sciences reported a second-quarter 2026 revenue of $3 million, marking a 7% sequential decline and a 17% decrease year-over-year as the company faced challenges in the CBD market. Despite the downturn, the company is focused on reducing costs and moving toward sustainable profitability, while maintaining gross margins around 48%. CV Sciences plans to expand its wellness portfolio and continue launching cannabinoid products amid ongoing regulatory challenges in the hemp-derived industry.Seeking AlphaCV Sciences outlines hemp-rule delay to December 11, 2026 while expanding PlusHLTH.com and planning multiple 2026 launches (OTCMKTS:CVSI)CV Sciences reported on its Q2 2026 performance, emphasizing a strategic focus on maintaining strong margins and reducing costs to achieve sustainable profitability. The company outlined plans to expand its PlusHLTH.com platform and prepare for multiple product launches in 2026. Additionally, management noted the delay of new hemp regulations until December 11, 2026.BenzingaCV Sciences Q2 2026 Earnings Call Transcript - CV SCIENCES INC by CV Sciences, Inc. (OTC:CVSI)CV Sciences reported Q2 2026 revenue of $3 million, a sequential decline driven by reduced unit sales, while successfully reducing operating expenses by 7.9% and generating positive operating cash flow. The company launched its new Plus Health direct-to-consumer website to diversify into non-cannabinoid wellness products amid ongoing regulatory challenges in the hemp industry. Management highlighted a recent U.S. Senate approval delaying key hemp regulations as a positive development that provides time for legislative solutions.FinancialContent Business PageCV Sciences, Inc. Reports Second Quarter-End 2026 Financial ResultsCV Sciences reported a 17.5% decline in second-quarter revenue to $3.0 million and a net loss of $775,000 for the quarter ended June 30, 2026, driven by lower sales volumes resulting from restrictive federal and state hemp regulations. The company offset some financial pressure by reducing operating expenses by 11.3% and launching new wellness products under its PlusHLTH brand alongside a dedicated e-commerce platform.Stock TitanCV Sciences Launches PlusHLTH.com Health PlatformCV Sciences, Inc. has launched PlusHLTH.com, a new direct-to-consumer website dedicated exclusively to its +PlusHLTH™ product line, marking a strategic expansion beyond its core hemp-derived CBD business into the broader health and nutrition market. The new platform is built around the company's Health Intelligence approach, combining science-backed non-cannabinoid nutritional products including dietary supplements and plant-based protein with educational content for consumers focused on healthy aging. The company plans to use the platform as the primary digital home for future product introductions and innovation under the +PlusHLTH™ brand.FinancialContent Business PageCV Sciences Launches PlusHLTH.com, Expanding Its Consumer Platform Beyond CannabinoidsCV Sciences, Inc. launched PlusHLTH.com, a new direct-to-consumer website dedicated exclusively to its +PlusHLTH™ product line of non-cannabinoid nutritional supplements and wellness products. The platform represents the company's strategic expansion beyond its core hemp-derived CBD business into broader health and nutrition markets focused on healthy aging, performance, and everyday wellness. CV Sciences plans to use the new digital destination to introduce new product formulations, deliver educational content, and establish a distinct brand identity for the +PlusHLTH™ line.MorningstarCV Sciences Launches PlusHLTH.com, Expanding Its Consumer Platform Beyond CannabinoidsCV Sciences launched PlusHLTH.com, a direct-to-consumer site for its non-cannabinoid +PlusHLTH product line. The site supports healthy aging and everyday health, with products including dietary supplements and Empowr plant-based protein. The company plans to expand the line with new formulations.FinanzNachrichten.deCV Sciences, Inc.: CV Sciences Launches PlusHLTH.com, Expanding Its Consumer Platform Beyond CannabinoidsCV Sciences, Inc. announced the launch of PlusHLTH.com, a new direct-to-consumer website dedicated to its +PlusHLTH non-cannabinoid health product line, marking a strategic expansion beyond its core hemp-derived CBD business. The platform is built around the company's "Health Intelligence" approach, offering science-backed dietary supplements and educational content focused on healthy aging, active lifestyles, and everyday wellness. The company plans to use this platform as the primary digital home for future product introductions and innovation as it grows its presence in the broader health and nutrition market.FinancialContent Business PageCV Sciences, Inc. to Announce Second Quarter 2026 Results on August 13, 2026CV Sciences, Inc. announced it will release its second quarter 2026 financial results on August 13, 2026, with a conference call and webcast scheduled for the same day. The company, based in the US, specializes in hemp extracts, nutraceuticals, and plant-based foods, with its products distributed globally.